Contract manufacturing said to be slowing; Lubrizol buys Particle Sciences;

> A new industry report says that growth of the biopharmaceutical contract manufacturing sector is likely to be slow because of high levels of capital investment by drugmakers. Report

> Bethlehem, PA-based CDMO Particle Sciences has been acquired by Lubrizol. Report

> A new report estimates that between 27% and 30% of India's $15 billion domestic drug business is controlled by foreign nationals. Release

> India is considering having thousands of drugmakers upgrade to PICS standards to help them access about 45 export markets. Report

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.